UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

Mediterranean journal of hematology and infectious diseases, 2023-01, Vol.15 (1), p.e2023012

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

Mediterranean journal of hematology and infectious diseases, 2024-04, Vol.16 (1), p.e2024047-e2024047

2024

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Infectious prophylaxis in hematological malignancies

Frontiers in oncology, 2023-05, Vol.13, p.1163175

2023

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

Frontiers in oncology, 2023-06, Vol.13, p.1212638

2023

Link zum Volltext

Verfügbarkeit prüfen

Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up

Mediterranean journal of hematology and infectious diseases, 2024, Vol.16 (1), p.e2024020-e2024020

2024

Link zum Volltext

Verfügbarkeit prüfen

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP

Mediterranean journal of hematology and infectious diseases, 2022, Vol.14 (1), p.e2022011-e2022011

2022

Link zum Volltext

Verfügbarkeit prüfen

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?

Mediterranean journal of hematology and infectious diseases, 2023-01, Vol.15 (1), p.e2023018-e2023018

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

Mediterranean journal of hematology and infectious diseases, 2024-03, Vol.16 (1), p.e2024041-e2024041

2024

Link zum Volltext

Verfügbarkeit prüfen

Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient

Nuclear Medicine and Molecular Imaging , 2020, 54(5), , pp.256-260

2020

Link zum Volltext

Verfügbarkeit prüfen

A Case of Fatal Hyperammonaemic Encephalopathy in a Patient with End-Stage Multiple Myeloma

Mediterranean journal of hematology and infectious diseases, 2023, Vol.15 (1), p.e2023012-e2023012

2023

Link zum Volltext

Verfügbarkeit prüfen

Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

British journal of haematology, 2024-05, Vol.204 (5), p.2129-2132

2024

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation

European journal of haematology, 2024-06, Vol.112 (6), p.938-943

2024

Link zum Volltext

Verfügbarkeit prüfen

CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases

Leukemia & lymphoma, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-3

2023

Link zum Volltext

Verfügbarkeit prüfen

One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission

European journal of haematology, 2023-12, Vol.111 (6), p.970-972

2023

Link zum Volltext

Verfügbarkeit prüfen

Systemic mastocytosis: 2023 update on diagnosis and management in adults

Expert opinion on emerging drugs, 2023-07, Vol.ahead-of-print (ahead-of-print), p.1-13

2023

Link zum Volltext

Verfügbarkeit prüfen

Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort

European journal of haematology, 2024-04, Vol.112 (4), p.654-657

2024

Link zum Volltext

Verfügbarkeit prüfen

Reduced Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic

Infection control and hospital epidemiology, 2022-12, Vol.43 (12), p.1963-1965

2022

Link zum Volltext

Verfügbarkeit prüfen

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP: immune thrombocytopenia following mRNA vaccine

Mediterranean journal of hematology and infectious diseases, 2022-01, Vol.14 (1), p.e2022011

2022

Link zum Volltext

Verfügbarkeit prüfen

Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura

Journal of clinical apheresis, 2021-06, Vol.36 (3), p.499-504

2021

Link zum Volltext

Verfügbarkeit prüfen

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Blood, 2018-11, Vol.132 (Supplement 1), p.1746-1746

2018

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Infectious prophylaxis in hematological malignancies

Frontiers in oncology, 2023, Vol.13, p.1163175-1163175

2023

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

Frontiers in oncology, 2023, Vol.13, p.1212638-1212638

2023

Link zum Volltext

Verfügbarkeit prüfen

Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura

Journal of clinical apheresis, 2021, Vol.36 (3), p.499-504

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient

Nuclear medicine and molecular imaging, 2020, Vol.54 (5), p.256-260

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(21)
Berichte
(4)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A case of fatal hyperammonaemic encephalopathy in a patient with end-stage Multiple Myeloma treated with daratumumab

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

Case Report: Infectious prophylaxis in hematological malignancies

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up

Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP

Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?

Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

P971: EFFECT OF DARATUMUMAB ON STEM CELL YIELDS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: REPORT FROM THE MULTIPLE MYELOMA LAZIO GROUP

Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient

A Case of Fatal Hyperammonaemic Encephalopathy in a Patient with End-Stage Multiple Myeloma

Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series

Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation

CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases

One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission

Systemic mastocytosis: 2023 update on diagnosis and management in adults

Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort

Reduced Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP: immune thrombocytopenia following mRNA vaccine

Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Case Report: Infectious prophylaxis in hematological malignancies

Case Report: Avelumab and ruxolitinib to manage polycythemia vera and secondary metastatic Merkel cell carcinoma: a possible successful combination

Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura

Acute Promyelocytic Leukemia After Radium-223 Exposure for Prostate Cancer in a Chemotherapy-Naïve Patient

Suchergebnisse filtern